Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith M Kerr

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
Lung Cancer (Amsterdam, Netherlands)|November 26, 2008
Pathologist and molecular biologist, ever the twain shall meet?Keith M Kerr
Archives of Pathology & Laboratory Medicine|October 2, 2012
Classification of lung cancer: proposals for change?Keith M Kerr
Histopathology|September 16, 2011
Personalized medicine for lung cancer: new challenges for pathologyKeith M Kerr
Journal of Clinical Pathology|April 9, 2013
Clinical relevance of the new IASLC/ERS/ATS adenocarcinoma classificationKeith M Kerr
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 24, 2018
The PD-L1 Immunohistochemistry Biomarker: Two Steps Forward, One Step Back?Keith M Kerr
Histopathology|February 4, 2009
Pulmonary adenocarcinomas: classification and reportingKeith M Kerr
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2014
ALK testing in non-small cell lung carcinoma: what now?Keith M Kerr
Archives of Pathology & Laboratory Medicine|March 2, 2016
Non-Small Cell Lung Cancer, PD-L1, and the PathologistKeith M Kerr, Marianne C Nicolson
Archives of Pathology & Laboratory Medicine|January 13, 2016
Programmed Death Ligand-1 Immunohistochemistry: Friend or Foe?Keith M Kerr, Fred R Hirsch
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Prognostic factors in resected lung carcinomasKeith M Kerr, Marianne C Nicolson
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Lung Cancer (Amsterdam, Netherlands)|November 26, 2008
Pathologist and molecular biologist, ever the twain shall meet?Keith M Kerr
Archives of Pathology & Laboratory Medicine|October 2, 2012
Classification of lung cancer: proposals for change?Keith M Kerr
Histopathology|September 16, 2011
Personalized medicine for lung cancer: new challenges for pathologyKeith M Kerr
Journal of Clinical Pathology|April 9, 2013
Clinical relevance of the new IASLC/ERS/ATS adenocarcinoma classificationKeith M Kerr
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 24, 2018
The PD-L1 Immunohistochemistry Biomarker: Two Steps Forward, One Step Back?Keith M Kerr
Histopathology|February 4, 2009
Pulmonary adenocarcinomas: classification and reportingKeith M Kerr
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2014
ALK testing in non-small cell lung carcinoma: what now?Keith M Kerr
Archives of Pathology & Laboratory Medicine|March 2, 2016
Non-Small Cell Lung Cancer, PD-L1, and the PathologistKeith M Kerr, Marianne C Nicolson
Archives of Pathology & Laboratory Medicine|January 13, 2016
Programmed Death Ligand-1 Immunohistochemistry: Friend or Foe?Keith M Kerr, Fred R Hirsch
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Prognostic factors in resected lung carcinomasKeith M Kerr, Marianne C Nicolson
Pageof 12